Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01255865 · ClinicalTrials.gov registry record
Comparison Study of Core Temperature Thermometry Systems
A clinical trial of Thermometry Device Comparisons, sponsored by 3M.
- Completed
- Registry status
- 111
- Enrollment target
- 1
- Study location
NCT01255865: Completed study of Thermometry Device Comparisons, sponsored by 3M.
NCT01255865 is a study of Thermometry Device Comparisons that has completed, run by 3M. The registered enrollment target is 111 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01255865, a study of Thermometry Device Comparisons, has completed, sponsored by 3M.
- COMPLETED
- Registry status
- 111 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this trial is the generation of clinical data required for a 510(k) submission to the FDA.
Primary Outcome
Temperature Agreement/Bias (Zero heat flux thermometry temperature minus oral or rectal temperature) between simultaneously-acquired oral or rectal and forehead deep tissue temperatures.
Conditions Studied
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-12 |
What the finished NCT01255865 record still lists
NCT01255865 is an observational study that tracks outcomes without assigning an intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Thermometry Device Comparisons appearing as the primary indexed condition, and to 0 interventions.
NCT01255865 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01255865 about?
NCT01255865 is a clinical study titled "Comparison Study of Core Temperature Thermometry Systems". The purpose of this trial is the generation of clinical data required for a 510(k) submission to the FDA.
What is the current status of trial NCT01255865?
This trial is currently completed. The enrollment target is 111 participants. The study started on 2010-12. Estimated completion is 2011-12.
What conditions does trial NCT01255865 study?
This clinical trial studies the following conditions: Thermometry Device Comparisons.
Who is sponsoring clinical trial NCT01255865?
This trial is sponsored by 3M, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01255865 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03875716 · 111 participants · NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- NCT04693468 · 111 participants · Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- NCT05263050 · 111 participants · Phase 2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- NCT05600842 · 111 participants
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia